U.S. News & World Report Publishes First GLP‑1 Telehealth Platform Rankings for 2026‑2027

U.S. News & World Report releases its inaugural set of ratings for GLP‑1 telehealth platforms, covering the 2026‑2027 cycle, marking the first time the publication has evaluated remote services that prescribe and manage GLP‑1 medications.

The rating methodology examines each platform’s ability to deliver GLP‑1 therapy online, considering factors such as patient access, clinical outcomes, and the integration of digital health tools, following the outlet’s established health‑service ranking standards.

The published list ranks the top platforms, identifying those that meet the publication’s criteria for excellence in GLP‑1 telehealth delivery, and distinguishes them from lower‑performing services.

Stakeholders including patients, clinicians, and insurers can use the rankings to compare options, assess quality, and make more informed decisions about which telehealth providers to select for GLP‑1 treatment management during the 2026‑2027 evaluation period.